WEDGE CAPITAL MANAGEMENT L L P/NC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1015308 CHARLOTTE, NC

Back to SUPN Full portfolio

Position in SUPN

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$3,203,841

-$396,005 QoQ

Shares Held

68,885

-1.1% QoQ

Ownership

0.119%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#83

of 331 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 33% Shared 0% None 67%

Common Shares in SUPN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WEDGE CAPITAL MANAGEMENT L L P/NC holds $47,806,751 across 8 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (6.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	1,856,208	$29,476,583
2	BCRX	Biocryst Pharmaceuticals Inc	380,801	$3,808,010
3	SUPN	Supernus Pharmaceuticals, Inc. This page	68,885	$3,203,841
4	PBH	Prestige Consumer Healthcare Inc.	61,203	$2,893,065
5	COLL	Collegium Pharmaceutical, Inc	71,523	$2,589,132
6	PCRX	Pacira BioSciences, Inc.	94,554	$2,398,834
7	IRWD	Ironwood Pharmaceuticals Inc	435,650	$1,834,086
8	ANIP	Ani Pharmaceuticals Inc	19,367	$1,603,200

All Filings in SUPN

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,203,841	68,885	-1.1%	Shares	Sole	2026-07-10
2026-03-31	$3,599,846	69,643	-10.8%	Shares	Sole	2026-04-13
2025-12-31	$3,881,321	78,095	+12.2%	Shares	Sole	2026-01-14
2025-09-30	$3,325,275	69,581	-5.8%	Shares	Sole	2025-10-10
2025-06-30	$2,329,328	73,900	+9.8%	Shares	Sole	2025-07-11
2025-03-31	$2,203,616	67,286	+26.2%	Shares	Sole	2025-04-14
2024-12-31	$1,928,448	53,331	—	Shares	Sole	2025-01-15
No filing history on record for this holder in this stock.